Table 5.2Simplified dosing of co-trimoxazole prophylaxis for children

DrugStrength of tablet or oral liquid (mg or mg/5 ml)Number of tablets or ml by weight band once daily
3.0–5.9 kg6.0–9.9 kg10.0–13.9 kg14.0–19.9 kg20.0–24.9 kg25.0–34.9 kg
Co-trimoxazoleSuspension 200/40 mg per 5 ml2.5 ml5 ml5 ml10 ml10 ml
Tablets (dispersible) 100/20 mg12244
Tablets (scored) 400/80 mg0.50.5112
Tablets (scored) 800/160 mg0.50.51

From: 5, THE USE OF CO-TRIMOXAZOLE PROPHYLAXIS FOR HIV-RELATED INFECTIONS AMONG ADULTS, ADOLESCENTS AND CHILDREN

Cover of Guidelines on Post-Exposure Prophylaxis for HIV and the Use of Co-Trimoxazole Prophylaxis for HIV-Related Infections Among Adults, Adolescents and Children: Recommendations for a Public Health Approach
Guidelines on Post-Exposure Prophylaxis for HIV and the Use of Co-Trimoxazole Prophylaxis for HIV-Related Infections Among Adults, Adolescents and Children: Recommendations for a Public Health Approach: December 2014 supplement to the 2013 consolidated guidelines on the use of antiretroviral drugs for treating and preventing HIV infection.
Geneva: World Health Organization; 2014 Dec.
Copyright © World Health Organization 2014.

All rights reserved. Publications of the World Health Organization are available on the WHO website (www.who.int) or can be purchased from WHO Press, World Health Organization, 20 Avenue Appia, 1211 Geneva 27, Switzerland (tel.: +41 22 791 3264; fax: +41 22 791 4857; e-mail: tni.ohw@sredrokoob).

Requests for permission to reproduce or translate WHO publications –whether for sale or for non-commercial distribution– should be addressed to WHO Press through the WHO website (www.who.int/about/licensing/copyright_form/en/index.html).

NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.